Table 1 List of proteins cited in this review, with their localization, function, and main interactors
From: Mitochondria-associated ER membranes (MAMs) and lysosomal storage diseases
Protein | Localization | Function | Known interactors | References |
---|---|---|---|---|
β-galactosidase | Lysosome | Catalyzes the hydrolysis of a terminal β-linked galactose residue from ganglioside substrates and other glycoconjugates | Protective protein cathepsi A (PPCA), neuraminidase 1 (NEU1) | |
Cathepsin D | Lysosome | Aspartic-type endopeptidase activity | ||
Palmitoyl-protein thioesterase 1, PPT1 | Lysosome | Removes thioester-linked fatty acyl groups such as palmitate from cysteine residues | CLN5 | |
Tripeptidyl peptidase 1, TPP1 | Lysososome | Cleaves N-terminal tripeptides from substrates, and has weaker endopeptidase activity | CLN5 | |
PSS1 | ER face of the MAMs | Phosphatidylserine synthase 1 | ||
PSS2 | ER face of the MAMs | Phosphatidylserine synthase 2 | ||
PS- decarboxylase | Mitochondrial side of the MAMs | Phosphatidylserine- decarboxylase | ||
PE-methyltransferase, PEMT | MAMs | Phosphatidylethanolamine-methyltransferase | ||
Mdm10 | Mitochondria/MAMs | ERMES complex | Mdm34, Mmm1, Mdm12, Gem1 | |
Mdm34 | Mitochondria/MAMs | ERMES complex | Mdm10, Mmm1, Mdm12, Gem1 | |
Mmm1 | ER/MAMs | ERMES complex | Mdm34, Mmm10, Mdm12, Gem1 | |
Mdm12 | Cytosol/MAMs | ERMES complex | Mdm34, Mmm10, Mdm1, Gem1 | |
Lam6 | MAMs, vacuole-mitochondria patches, nuclear-vacuole contact sites | ERMES complex, vCLAMP (vacuole and mitochondria patch), and NVJ (nuclear vacuolar junction) | Mdm10, Mmm1, Mdm12, Mdm34, Vps39, Nvj1, Vac8 | |
Gem1 | MAMs | ERMES complex | Mdm10, Mmm1, Mdm12, Mdm34 | |
EMC1 | MAMs | EMC, PS transfer, MAMs architecture | TOM5 | |
EMC2 | MAMs | EMC, PS transfer, MAMs architecture | TOM5 | |
EMC3 | MAMs | EMC, PS transfer, MAMs architecture | TOM5 | |
EMC4 | MAMs | EMC, PS transfer, MAMs architecture | TOM5 | |
EMC5 | MAMs | EMC, PS transfer, MAMs architecture | TOM5 | |
EMC6 | MAMs | EMC, PS transfer, MAMs architecture | TOM5 | |
CLN8 | ER integral membrane protein | Transmembrane protein belonging to a family of proteins containing TLC domains, which are postulated to function in lipid synthesis, transport, or sensing. | CLN5 | |
Caspase 12 | ER | Member of the cysteine-aspartic acid protease family responsible for ER-stress-induced apoptosis | ||
PC- cytidyltransferase, CTP | Cytosol, MAMs | Involved in the regulation of phosphatidylcholine biosynthesis | ||
Acetyl-CoA:cholesterol acyltransferase, ACAT | MAMs | Catalyzes the reversible formation of acetoacetyl-CoA from two molecules of acetyl-CoA | ||
Steroidogenic acute regulatory protein, StaR | MAMs, mitochondria | Plays a key role in the acute regulation of steroid hormone synthesis by enhancing the conversion of cholesterol into pregnenolone | TOMM22, VDAC2 | |
Sigma-1 receptor | ER face of the MAMs | Interacts with a variety of psychotomimetic drugs, including cocaine and amphetamines. The receptor is believed to play an important role in the cellular functions of various tissues associated with the endocrine, immune, and nervous systems. | BiP, IP3R3 | |
VDAC-1 | Mitochondrial side of the MAMs | Facilitates the exchange of metabolites and ions across the outer mitochondrial membrane | Grp75 | |
IP3R-1 | ER, MAMs | Mediates calcium release from the endoplasmic reticulum following stimulation by inositol 1,4,5-trisphosphate | GRP75 | |
GRP75 | ER, mitochondria, MAMs | Member of the heat shock protein 70 gene family, functions as scaffold between IP3R-1 and VDAC1 | IP3R-1 and VDAC1 | |
BiP | ER, MAMs | Involved in the folding and assembly of proteins in the ER | Interacts with many ER proteins | |
Calnexin | ER, MAMs | Ca2+-binding protein that interacts transiently with newly synthesized N-linked glycoproteins, facilitating protein folding and assembly | PACS2, AMBRA1, WIPI1 | |
hFis1 | Mitochondria | Promotes mitochondrial fission | t-Bid, Bax,, VDAC1 | |
t-Bid | Mitochondria | Member of the BCL-2 family of cell death regulators | Eterodimerizes with either agonist BAX or antagonist BCL2, VDAC1 | |
Bax | Mitochondria | Member of the BCL-2 family of cell death regulators | BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators | |
LC3 | Autophagic vacuoles | LC3 (encoded by MAPLC3A and MAPLC3B) is the homolog of the yeast ATG8, an important marker and effector of autophagy | Microtubules, FYCO1, TP53INP1 and TP53INP2, TBC1D25, SQSTM1, ATG4B, MAPK15 and BNIP3, MAPB1, KEAP1, PCM1, OFD1, CEP131, TECPR2,TBC1D5, UBQLN1, UBQLN2, UBQLN4, UBQLN1, ATG13, FAM134A, FAM134B, FAM134C | |
AMBRA1 | Autophagic vacuoles | Regulates autophagy and development of the nervous system | BECN1, BECN2, BCL2, dynein light chains 1 and 2, WIPI1, calnexin | |
WIPI1 | Autophagic vacuoles | Plays an important role in autophagy and in particular starvation- and calcium-mediated autophagy | Interacts with androgen receptor (AR) and the estrogen receptors ESR1, and ESR2, calnexin | |
CHOP | Nucleus | CCAAT-enhancer-binding protein homologous protein | ||
JNK2 | Cytosol | JNKs (c-Jun N-terminal kinases) are a group of mitogen-activated protein kinases activated by various environmental stresses |